Stryker Corporation (SYK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Stryker Corporation (NYSE:SYK ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Jason Beach - Vice President of Finance & Investor Relations J....
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appo...
Gear Up for Stryker (SYK) Q1 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for so...
SYK Trades Below 52-Week High: Should You Buy, Hold or Sell the Stock?
Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is the stock still a buy?
Sales Growth, Strategic Acquisitions Drive Stryker Higher
Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.
SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans
SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
Stryker Corporation (NYSE:SYK ) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & N...
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates
Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago.
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices
Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive...
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to p...
Here's Why You Should Retain Stryker Stock in Your Portfolio for Now
SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
Stryker Gains 30.2% Year to Date: What's Driving the Stock?
SYK continues to witness growth on the back of a robust product line and strategic acquisitions.
Stryker Bringing in Big Money
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
Related Companies